ArticleBritish journal of cancer2022

Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients.

Chunnan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.